Lupin Pharmaceuticals announced the launch of Fenofibrate Tablets, the generic version of Abbott‘s Tricor

Fenofibrate is a fibrate indicated as adjunct to diet in hypertriglyceridemia (Types IV and V), and to reduce elevated total-C, LDL-C, apo B, and TG, and to increase HDL-C, in primary hypercholesterolemia and mixed dyslipidemia (Types IIa and IIb).  By activating the PPARα receptor, fenofibrate increases lipolysis and elimination of triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing production of apoprotein C-III.

Fenofibrate Tablets will be available in 48mg and 145mg dosage strengths. 

For more information call (866) 587-4617 or visit